Docket

40100

Pharmascience Inc., et al. v. Teva Canada Innovation, et al.

(Federal) (Civil) (By Leave)

(Certain information not available to the public)

Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.

Proceedings
Date Proceeding Filed By
(if applicable)
2022-10-27 Close file on Leave
2022-09-29 Copy of formal judgment sent to Registrar of the Court of Appeal and all parties
2022-09-29 Judgment on leave sent to the parties
2022-09-29 Judgment of the Court on the application for leave to appeal, The motion to join three Federal Court of Appeal files in a single application for leave to appeal is granted. The application for leave to appeal from the judgment of the Federal Court of Appeal, Numbers A-315-20, A-316-20 and A-4-21, 2022 FCA 2, dated January 6, 2022, is dismissed with costs.
Dismissed, with costs
2022-09-29 Decision on the miscellaneous motion, See decision on the application.
Granted
2022-08-15 All materials on application for leave submitted to the Judges, for consideration by the Court
2022-08-15 Submission of miscellaneous motion, for consideration by the Court
2022-07-12 Certificate (on limitations to public access), (Letter Form), CONFIDENTIAL / RESTRICTED

FIRST, SECOND, THIRD APPLICATION

23B - Reply

received:
-23B (rec'd 2022-07-12)
-Confidentiality Order (CONFIDENTIAL/RESTRICTED - rec'd electronic copy 2022-06-06 ; rec'd paper copy 2022-06-14), (Printed version due on 2022-07-19)
Pharmascience Inc.
2022-06-06 Applicant's reply to respondent's argument, (Book Form), CONFIDENTIAL / RESTRICTED

FIRST, SECOND, THIRD APPLICATION

Require: 23B (rec'd 2022-07-12), Completed on: 2022-07-12, (Printed version filed on 2022-06-14)
Pharmascience Inc.
2022-05-26 Notice of name, (Letter Form), (Printed version due on 2022-06-02) Yeda Research and Development Co., Ltd
2022-05-26 Notice of name, (Letter Form), (Printed version due on 2022-06-02) Teva Canada Innovation
2022-05-26 Notice of name, (Letter Form), (Printed version due on 2022-06-02) Teva Canada Limited
2022-05-26 Certificate (on limitations to public access), (Letter Form), 23B, (Printed version due on 2022-06-02) Teva Canada Innovation
2022-05-26 Certificate (on limitations to public access), (Letter Form), 23A, (Printed version due on 2022-06-02) Teva Canada Innovation
2022-05-26 Respondent's response on the application for leave to appeal, (Book Form), Respondent's response for - FIRST, SECOND & THIRD APPLICATION, Completed on: 2022-06-09, (Printed version filed on 2022-05-26) Teva Canada Innovation
2022-04-28 Letter acknowledging receipt of a complete application for leave to appeal, FILE OPENED - 2022-04-28_THIRD APPLICATION
2022-04-28 Letter acknowledging receipt of a complete application for leave to appeal, FILE OPENED - 2022-04-28_SECOND APPLICATION
2022-04-28 Letter acknowledging receipt of a complete application for leave to appeal, FILE OPENED - 2022-04-28_FIRST APPLICATION
2022-03-07 Notice of miscellaneous motion, (Letter Form), (2 volumes), FIRST, SECOND, THIRD APPLICATION

MOTION TO JOIN UNDER A SINGLE FILE, Completed on: 2022-04-27, (Printed version filed on 2022-05-27)
Pharmascience Inc.
2022-03-07 Certificate (on limitations to public access), (Letter Form), THIRD APPLICATION - A-316-20
23B, (Printed version filed on 2022-05-27)
Pharmascience Inc.
2022-03-07 Certificate (on limitations to public access), (Letter Form), THIRD APPLICATION - A-316-20
23A, (Printed version filed on 2022-05-27)
Pharmascience Inc.
2022-03-07 Application for leave to appeal, (Book Form), (2 volumes), THIRD APPLICATION, Completed on: 2022-04-28, (Printed version filed on 2022-05-27) Pharmascience Inc.
2022-03-07 Certificate (on limitations to public access), (Letter Form), SECOND APPLICATION - A-315-20
23B, (Printed version filed on 2022-05-27)
Pharmascience Inc.
2022-03-07 Certificate (on limitations to public access), (Letter Form), SECOND APPLICATION - A-315-20
23A, (Printed version filed on 2022-05-27)
Pharmascience Inc.
2022-03-07 Application for leave to appeal, (Book Form), (2 volumes), SECOND APPLICATION , Completed on: 2022-04-28, (Printed version filed on 2022-05-27) Pharmascience Inc.
2022-03-07 Notice of name, (Letter Form), FIRST, SECOND, THIRD APPLICATION, (Printed version filed on 2022-05-27) Pharmascience Inc.
2022-03-07 Certificate (on limitations to public access), (Letter Form), FIRST APPLICATION - A-4-21
23B, (Printed version filed on 2022-05-27)
Pharmascience Inc.
2022-03-07 Certificate (on limitations to public access), (Letter Form), FIRST APPLICATION - A-4-21
23A, (Printed version filed on 2022-05-27)
Pharmascience Inc.
2022-03-07 Application for leave to appeal, (Book Form), (2 volumes), FIRST APPLICATION , Completed on: 2022-04-28, (Printed version filed on 2022-05-27) Pharmascience Inc.